Streetbeat News

GRDN

Guardian Pharmacy Services, Inc.

Industry

Medical - Distribution

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Stephens & Co. has initiated coverage on Guardian Pharmacy Service with an Overweight rating and set a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 4:45 pm

Truist Securities has initiated coverage on Guardian Pharmacy Services, Inc (NYSE:GRDN) with a Buy rating and a price target of $22. The company, which recently went public, operates long-term care pharmacies and is well-positioned in a fragmented market with strong industry trends. Guardian's strategic focus on assisted living and behavioral health facilities, along with its financial flexibility, supports its growth potential.

Portfolio Pulse from Vandana Singh

October 21, 2024 | 6:54 pm

Several Wall Street analysts initiated coverage on key stocks with bullish ratings. Deutsche Bank rated GE Vernova (GEV) as Buy with a $354 target. Keybanc rated BKV Corporation (BKV) as Overweight with a $23 target. Jefferies rated Sarepta Therapeutics (SRPT) as Buy with a $165 target. Benchmark rated ESCO Technologies (ESE) as Buy with a $150 target. Truist Securities rated Guardian Pharmacy Services (GRDN) as Buy with a $22 target.

Portfolio Pulse from Avi Kapoor

October 21, 2024 | 1:01 pm

Truist Securities has initiated coverage on Guardian Pharmacy Service with a Buy rating and set a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 12:45 pm

Guardian Pharmacy Services' shares began trading at $14.50 per share, following an IPO priced at $14 per share for 8 million shares.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 2:40 pm

Guardian Pharmacy Services is launching an IPO with an initial price of $14 per share for 8 million shares. The IPO is indicating a price of $14.30 per share on 402,492 shares.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 2:28 pm

Guardian Pharmacy Services is launching an IPO with shares priced at $14 each, within the indicated range of $14-$14.50, and offering 8 million shares.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 2:13 pm

Guardian Pharmacy Services has raised $112 million through an initial public offering (IPO) of 8 million shares at $14 per share. The shares will begin trading on the NYSE under the symbol 'GRDN'.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:55 am

Guardian Pharmacy Services has announced its initial public offering (IPO) of 6.75 million shares priced between $14 and $16 per share. The shares will be listed on the NYSE under the symbol 'GRDN'. The company has also granted underwriters a 30-day option to purchase an additional 1,012,500 shares.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:08 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.